62.95
0.74%
0.4017
前日終値:
$62.55
開ける:
$63
24時間の取引高:
23,210
Relative Volume:
0.08
時価総額:
$1.86B
収益:
-
当期純損益:
$-91.00M
株価収益率:
-15.90
EPS:
-3.9598
ネットキャッシュフロー:
$-74.38M
1週間 パフォーマンス:
+3.86%
1か月 パフォーマンス:
+24.11%
6か月 パフォーマンス:
+101.57%
1年 パフォーマンス:
+21.76%
Disc Medicine Inc Stock (IRON) Company Profile
名前
Disc Medicine Inc
セクター
電話
(617) 674-9274
住所
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
IRON | 62.93 | 1.86B | 0 | -91.00M | -74.38M | -3.9598 |
VRTX | 447.00 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 741.05 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 587.23 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.40 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 102.75 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-08-22 | 開始されました | Wells Fargo | Overweight |
2024-04-01 | ダウングレード | Raymond James | Strong Buy → Outperform |
2023-12-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2023-06-09 | アップグレード | Raymond James | Outperform → Strong Buy |
2023-06-07 | 開始されました | H.C. Wainwright | Buy |
2023-05-17 | 開始されました | Raymond James | Outperform |
2023-04-28 | 開始されました | Cantor Fitzgerald | Overweight |
2023-04-21 | 開始されました | Stifel | Buy |
2023-04-20 | 開始されました | Morgan Stanley | Overweight |
2023-03-23 | 開始されました | BMO Capital Markets | Outperform |
2023-02-28 | 開始されました | SVB Securities | Outperform |
すべてを表示
Disc Medicine Inc (IRON) 最新ニュース
Disc Medicine secures $200m financing to support trials - MSN
Contrasting Pharming Group (OTCMKTS:PHGUF) and Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine chief medical officer sells $546,152 in stock - Investing.com
Disc Medicine chief medical officer sells $546,152 in stock By Investing.com - Investing.com UK
Disc Medicine Announces New Equity Sales Agreement - TipRanks
FY2024 EPS Estimates for Disc Medicine Raised by Analyst - MarketBeat
Wedbush Forecasts Disc Medicine's Q4 Earnings (NASDAQ:IRON) - MarketBeat
Disc Medicine FY2024 EPS Estimate Raised by Leerink Partnrs - MarketBeat
Lifesci Capital Predicts Stronger Earnings for Disc Medicine - MarketBeat
Disc Medicine FY2024 EPS Forecast Boosted by HC Wainwright - MarketBeat
Paradigm Biocapital Advisors LP Adjusts Stake in Disc Medicine I - GuruFocus.com
Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) PT at $85.80 - MarketBeat
FY2028 Earnings Forecast for Disc Medicine Issued By Wedbush - MarketBeat
Disc Medicine Reports Q3 2024 Results and Strategic Progress - TipRanks
Disc Medicine (NASDAQ:IRON) Announces Quarterly Earnings Results - MarketBeat
Disc Medicine to Participate in Upcoming Investor Conferences - The Manila Times
Disc Medicine stock gets price target bump from H.C. Wainwright, Buy rating intact - Investing.com UK
Disc Medicine (IRON) to Present at Major Healthcare Investor Conferences | IRON Stock News - StockTitan
Learn to Evaluate (IRON) using the Charts - Stock Traders Daily
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Disc Medicine Secures $200M Financing, Reports FDA Fast-Track Potential for Key Drug | IRON Stock News - StockTitan
Disc Medicine Inc. (IRON) Quarterly 10-Q Report - Quartz
Disc Medicine secures $200M in debt financing from Hercules Capital - MSN
Scotiabank Boosts Disc Medicine (NASDAQ:IRON) Price Target to $70.00 - Defense World
Wellington Management Group LLP Increases Stake in Disc Medicine Inc - GuruFocus.com
Disc Medicine Leaps on Investment - Baystreet.ca
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital - citybiz
Disc Medicine Secures $200 Million in Financing - citybiz
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc. - The Manila Times
Disc Medicine Secures Massive $200M Financing Deal to Advance Clinical Pipeline | IRON Stock News - StockTitan
FY2024 Earnings Forecast for Disc Medicine Issued By Wedbush - Defense World
Leerink Partnrs Forecasts Weaker Earnings for Disc Medicine - MarketBeat
Disc Medicine (NASDAQ:IRON) Stock Rating Upgraded by Raymond James - Defense World
FY2024 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine (IRON) Rally Strengthens With After-Hour Gains On Positive Clinical Milestone - Stocks Telegraph
Disc medicine director sells $427,525 in stock By Investing.com - Investing.com South Africa
Disc medicine director sells $427,525 in stock - Investing.com
Disc Medicine (NASDAQ:IRON) Stock Price Up 7%Here's Why - MarketBeat
HC Wainwright Reaffirms Buy Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat
Scotiabank upgrades Disc Medicine shares target on trial update By Investing.com - Investing.com UK
Disc Medicine to Present Complete DISC-0974 Trial Data, Portfolio Updates at ASH 2024 | IRON Stock News - StockTitan
Disc Medicine stock target upgraded on bitopertin prospects By Investing.com - Investing.com Canada
Disc Medicine (NASDAQ:IRON) Upgraded at Morgan Stanley - MarketBeat
FDA aligns with Disc Medicine on EPP treatment study - Investing.com India
Wedbush Reaffirms Outperform Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat
Disc over the moon as FDA urges Apollo bid with bitopertin in EPP - BioWorld Online
FDA aligns with Disc Medicine on EPP treatment study By Investing.com - Investing.com Canada
Disc Medicine stock rallies 26% on FDA update for bitopertin (update) - Seeking Alpha
Disc Medicine Shares Rise After Positive Feedback From FDA - Marketscreener.com
Disc Medicine (NASDAQ:IRON) Shares Gap UpTime to Buy? - MarketBeat
Disc Medicine Inc (IRON) 財務データ
収益
当期純利益
現金流量
EPS
Disc Medicine Inc (IRON) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Savage William Jacob | Chief Medical Officer |
Nov 15 '24 |
Sale |
59.64 |
9,158 |
546,153 |
40,405 |
大文字化:
|
ボリューム (24 時間):